$110 billion OpenAI, SpaceX and crypto-payments operator RedotPay: What's important about the IPO by March 1

Amazon, Nvidia and SoftBank invested $110 billion in OpenAI - the company has completed its funding round, having raised a total of more than twice as much money as in the previous investment round. SpaceX plans to file a confidential IPO in March and expects a valuation of $1.75 trillion, Bloomberg has learned. That said, its listing, the largest in history, is forcing other companies to reconsider going public. Chinese service of payments in steblecoins RedotPay may in 2026 place shares in the U.S. for $1 billion. The main events on the IPO market for the week - in our selection.

- SpaceX plans to confidentially file an IPO application with the Securities and Exchange Commission as early as March, sources told Bloomberg. According to some of them, the company can expect a valuation of more than $1.75 trillion. If the documents are filed in March, it will allow the offering to take place in June, the agency points out. Earlier, the Financial Times wrote that SpaceX is considering a mid-June listing because Musk wants to time it to coincide with a rare planetary convergence known as a planetary parade and his own birthday. Bloomberg's interlocutors clarify that discussions are still ongoing, details could change, and the company could delay the filing.

- OpenAI announced the completion of a round of financing totaling $110 billion. Amazon invested in OpenAI $50 billion (although earlier sources of The Information reported that the company plans to transfer to OpenAI at once only $15 billion, and the remaining $35 billion - after the IPO or a breakthrough in the creation of AI capable of human-level thinking), Nvidia and SoftBank invested $30 billion each. As a result of the deal, OpenAI was valued at $730 billion. The results of this round more than doubled the amount of last year's fundraising OpenAI, which then became a record for a private tech company, indicates CNBC. OpenAI is preparing for listing in 2026 with a valuation of up to $1 trillion.

- RedotPay , a Hong Kong-based operator of payments in stablecoins, is preparing an IPO in the U.S. worth more than $1 billion, Bloomberg sources say. They claim that the listing in New York could take place this year, and it is being organized by major investment banks: JPMorgan, Goldman Sachs and Jefferies. The cryptocurrency platform was granted unicorn status in 2025. As of November, the startup had a customer base of more than 6 million users.

- One of the world's largest medical device suppliers Medtronic intends to float its diabetes device subsidiary MiniMed Group on Nasdaq in early March. In its IPO filing, MiniMed said it plans to float up to $784 million worth of shares at prices ranging from $25 to $28 apiece. Final pricing is scheduled for March 5. The company makes a line of automated insulin pumps and continuous glucose monitoring systems. MiniMed's securities will trade under the ticker MMED.

- Global Medical Response (GMR), one of the largest ambulance services in the U.S., is planning an IPO worth about $1 billion, Bloomberg sources said. According to them, the company has already hired banks JPMorgan Chase and Bank of America to prepare the initial public offering. GMR was created by investment fund KKR by merging helicopter service Air Medical Group and ground ambulance operator American Medical Response. KKR acquired them in 2015-2017, paying a total of $4.5 billion. According to GMR, its services are used by more than 62% of people in the United States.

- Swiss agrochemical giant Syngenta, part of Chinese holding ChemChina, plans to hold one of the largest IPOs of the current year in the fourth quarter, sources told Reuters. According to them, Syngenta will apply for a share offering in Hong Kong between April and June. In early February, it became known that the volume of placement may reach $10 billion. Two years ago Syngenta tried to hold an IPO in Shanghai, but plans had to be canceled due to weakness of the stock market in China. Competitors Syngenta in the global market for seeds and plant protection of $120 billion are Corteva, Bayer and BASF.

- Billionaire Paul Singer's investment fund Elliott Management, which owns book chains Barnes & Noble and Waterstones Booksellers, has started preparations for their IPO, Bloomberg reported citing sources. According to them, Elliott is considering a joint listing of both networks in London, although the New York option is also possible. American Barnes & Noble and British Waterstones have been able to survive in the book market despite stiff competition from Amazon, Bloomberg points out. Placing their shares will be a boost for the London Stock Exchange, which has seen a modest revival in IPOs in 2025.

- Generate Biomedicines, a drug developer invested in by Nvidia, raised $400 million in an IPO on Nasdaq. The company sold 25 million shares at $16 apiece, which is in the middle of its price range. According to Bloomberg, the order book was oversubscribed and the startup's capitalization reached $2 billion. Nvidia and Mirae Asset Group previously invested in Generate Biomedicines, while Novartis and Amgen have partnered with the startup. In 2026, the biotech industry is experiencing a boom of initial public offerings in the US. The volume of such IPOs has reached $1.4 billion since the beginning of the year, compared to $915 million in the same period in 2025, Bloomberg calculated.

- Preparing SpaceX for the largest IPO in history changes the road map for other companies planning to go public in 2026, writes Bloomberg. Elon Musk's corporation is expected to raise up to $50 billion. Because of this, issuers with standard IPO volumes have to revise their schedules. Placement of SpaceX shares will inevitably capture all the attention of large funds, and those may simply not notice smaller deals, explained the head of equity capital markets EQT Magnus Thornling. His private equity fund plans to float its projects at least a month and a half before SpaceX.

This article was AI-translated and verified by a human editor